Industry spots worrying loose ends in the draft In Vitro Diagnostic (IVD) Directive
This article was originally published in Clinica
Executive Summary
Manufacturers could face a number of overwhelming obstacles when the IVD Directive first comes into force unless a series of practical issues are resolved now, delegates heard at the RAPS conference on the IVD Directive on December 9 in Brussels.